Description
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. The company has a comprehensive portfolio of drugs under development for various types of cancer, including a variety of monoclonal antibody drugs, antibody-conjugated ADCs, and special oncology drugs. It generates revenues from Mainland China.
